Elisabeth O’Flaherty
ORCID: 0000-0001-9056-5790
· 1 paper in corpus
article
2019
Selective androgen receptor modulators (SARMs) have been proposed as therapeutics for women suffering from breast cancer, muscle wasting or urinary incontinence. The androgen receptor (AR) is expressed in the uterus but the impact of SARMs …